These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 15806306

  • 21. Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells.
    Koumbadinga GA, Désormeaux A, Adam A, Marceau F.
    Eur J Pharmacol; 2010 Nov 25; 647(1-3):117-25. PubMed ID: 20813106
    [Abstract] [Full Text] [Related]

  • 22. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J, Bu J, Hao Y, Chen F.
    Prostate Cancer Prostatic Dis; 2005 Nov 25; 8(3):274-9. PubMed ID: 15897917
    [Abstract] [Full Text] [Related]

  • 23. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 24. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V, Bodner B, Qin JZ, Nickoloff BJ.
    J Dermatol Sci; 2006 Jan 15; 41(1):31-41. PubMed ID: 16289694
    [Abstract] [Full Text] [Related]

  • 25. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
    Ou D, Wang X, Metzger DL, Robbins M, Huang J, Jobin C, Chantler JK, James RF, Pozzilli P, Tingle AJ.
    Hum Immunol; 2005 Jul 15; 66(7):799-809. PubMed ID: 16112027
    [Abstract] [Full Text] [Related]

  • 26. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Horak P, Pils D, Kaider A, Pinter A, Elandt K, Sax C, Zielinski CC, Horvat R, Zeillinger R, Reinthaller A, Krainer M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8585-91. PubMed ID: 16361541
    [Abstract] [Full Text] [Related]

  • 27. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Jul 15; 18(1):41-7. PubMed ID: 16786154
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
    Tong HX, Zhang JH, Ma L, Lu CW, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug 15; 8(4):327-30. PubMed ID: 16923369
    [Abstract] [Full Text] [Related]

  • 33. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 34. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
    Oshima K, Yanase N, Ibukiyama C, Yamashina A, Kayagaki N, Yagita H, Mizuguchi J.
    Cytokine; 2001 May 21; 14(4):193-201. PubMed ID: 11448118
    [Abstract] [Full Text] [Related]

  • 35. Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-kappaB but is related to downregulation of initiator caspases and DR4.
    Kurbanov BM, Fecker LF, Geilen CC, Sterry W, Eberle J.
    Oncogene; 2007 May 17; 26(23):3364-77. PubMed ID: 17160022
    [Abstract] [Full Text] [Related]

  • 36. Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing.
    Siegmund D, Wicovsky A, Schmitz I, Schulze-Osthoff K, Kreuz S, Leverkus M, Dittrich-Breiholz O, Kracht M, Wajant H.
    Mol Cell Biol; 2005 Aug 17; 25(15):6363-79. PubMed ID: 16024776
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug 17; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 38. Activation of the Jak-STAT-signaling pathway in embryonic lens cells.
    Potts JD, Kornacker S, Beebe DC.
    Dev Biol; 1998 Dec 01; 204(1):277-92. PubMed ID: 9851859
    [Abstract] [Full Text] [Related]

  • 39. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
    Fulda S, Debatin KM.
    Oncogene; 2002 Apr 04; 21(15):2295-308. PubMed ID: 11948413
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.